2 March 2023 ASA rejects ‘vaping to quit smoking’ claims A recent ASA ruling highlighted the risks of making smoking cessation claims for products without a relevant MHRA licence. An... ASA rejects ‘vaping to quit smoking’ claims
27 February 2023 PAGB welcomes “very positive outcome” securing supply of medicines for Northern Ireland and UK PAGB welcomes today’s announcement and the positive outcome of these negotiations. We have always said that it is important that... PAGB welcomes “very positive outcome” securing supply of medicines for Northern Ireland and UK
23 February 2023 PAGB statement on the review of pseudoephedrine Available for over 40 years and with a well-established safety profile, pseudoephedrine is an active ingredient which is used as... PAGB statement on the review of pseudoephedrine
20 February 2023 Mail on Sunday coverage of over-the-counter medicines supply Michelle Riddalls, Chief Executive of PAGB, the consumer healthcare association, which represents the manufacturers of over-the counter-medicines (OTC)... Mail on Sunday coverage of over-the-counter medicines supply
15 February 2023 CAP guidance on environmental claims: ‘carbon neutral’ and ‘net zero’ claims The ASA has published updated guidance on environmental claims in advertising, advising marketers to avoid using unqualified carbon neutral, net... CAP guidance on environmental claims: ‘carbon neutral’ and ‘net zero’ claims
14 February 2023 PAGB response to the BBC’s coverage of salt levels in soluble OTC medicines Michelle Riddalls, PAGB Chief Executive: “The comparison by the Morning Live programme of salt content in soluble products, versus... PAGB response to the BBC’s coverage of salt levels in soluble OTC medicines
2 February 2023 ASA ruling on using comparative nutrition claims A recent ASA ruling gives an example of what not to do when using these types of... ASA ruling on using comparative nutrition claims
26 January 2023 MailOnline article on salt levels in soluble OTC medicines, PAGB response PAGB response to MailOnline article on salt levels in soluble OTC medicinesMichelle Riddalls, PAGB Chief Executive: “The sodium in effervescent... MailOnline article on salt levels in soluble OTC medicines, PAGB response
18 January 2023 Cooperation and negotiation key to continuing a secure supply of medicines to Northern Ireland: PAGB CEO gives evidence to House of Lords Cooperation and negotiation key to continuing a secure supply of medicines to Northern Ireland: PAGB CEO gives evidence to House... Cooperation and negotiation key to continuing a secure supply of medicines to Northern Ireland: PAGB CEO gives evidence to House of Lords
14 January 2023 PAGB response to Daily Mail story on medicine pricing PAGB statement on branded medicines Michelle Riddalls, PAGB Chief Executive, says:“Branded over-the-counter (OTC) products on the market in the UK... PAGB response to Daily Mail story on medicine pricing
9 January 2023 Open letter calling for the development and implementation a national self-care strategy PAGB’s Chief Executive, Michelle Riddalls, has co-signed an open letter, published in the Times today calling on... Open letter calling for the development and implementation a national self-care strategy
15 December 2022 PAGB welcomes government’s announcement on batch testing of medicinal products Today, the Department of Health and Social has published the outcome from the ‘Future strategy for batch testing of medicinal... PAGB welcomes government’s announcement on batch testing of medicinal products
